Related Experiment Video
Updated: Jun 3, 2026

06:51
Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Selective Immune Reprogramming or Broad Immune Ablation with BCMA-CD19 Dual-Targeted CAR-T Cells in AL Amyloidosis
Amir Muhammad1,2, Janjua Muhammad Usman3, Ling Yuan2
1Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Journal of the American Society of Nephrology : JASN
|June 1, 2026
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

